SHABANA AHMED: Open Payments
NPI 1790955219 · REDFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 99 payments from 9 companies in 2025. Trend: 2023 $1,170 · 2024 $1,243 · 2025 $1,493
Food & beverage: $1,343Education: $150
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $336 |
| Teva Pharmaceuticals USA, Inc. | 15 | $233 |
| Otsuka America Pharmaceutical, Inc. | 22 | $233 |
| E.R. Squibb & Sons, L.L.C. | 17 | $170 |
| Lundbeck LLC | 8 | $159 |
| Janssen Pharmaceuticals, Inc | 9 | $149 |
| Alkermes, Inc. | 5 | $115 |
| ABBVIE INC. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
Products named: INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, UZEDY, ABILIFY MAINTENA, VRAYLAR, LYBALVI.
Industry payments across MI — which companies pay providers there.
